Align Technology | ALGN - Profitto Lordo Sulle Vendite

Prezzo Delle Azioni
176.18
Cambio Giornaliero
-2.22 -1.24%
Mensile
2.77%
Annuale
-0.32%
Q2 Previsione
185.55




Profitto Lordo Sulle Vendite Cambiamento Data
3M USD 2.46B 398M 2026-03
Align Technology USD 736.59M 53M 2026-03
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bruker USD 449.2M 69.8M 2025-12
Cardinal Health USD 2.5B 101M 2026-03
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
CVS Health USD 13.57B 239M 2025-12
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 443M 2M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Henry Schein USD 1.06B 37M 2025-12
Idexx Laboratories USD 658.11M 25.24M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Masimo USD 247.3M 16.7M 2025-12
McKesson USD 3.68B 143M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Solventum Corp USD 1.03B 108M 2025-12
Stryker USD 4.49B 633M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veeva Systems USD 622.47M 7.11M 2025-12
Waters USD 557.42M 97.44M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12
Zoetis USD 1.64B 73M 2025-12